Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, June 23, 2023
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
Thu, June 22, 2023
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
David Nierengarten Initiated (TCRX) at Buy and Held Target at $8 on, Jun 22nd, 2023
David Nierengarten of Wedbush, Initiated "TScan Therapeutics, Inc." (TCRX) at Buy and Held Target at $8 on, Jun 22nd, 2023.
David has made no other calls on TCRX in the last 4 months.
There is 1 other peer that has a rating on TCRX. Out of the 1 peers that are also analyzing TCRX, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Thursday, May 18th, 2023
